Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer

Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer

A few study has proven that about 90% of local control rates might be benefit from stereotactic body radiotherapy (SBRT) for patients with medically inoperable stage I non-small cell lung cancer (NSCLC), it is reported SBRT associated overall survival and tumor specific survival is comparable with t...

Full description

Bibliographic Details
Main Authors: Yuming WAN, Jing HUANG, Feng XU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2018-05-01
Series:Chinese Journal of Lung Cancer
Subjects:
Stereotactic body radiotherapy
Centrally
Lung neoplasms
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2018.05.10

Similar Items

Similar Items